191 related articles for article (PubMed ID: 27913539)
21. Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.
Casella JF; Adams RJ; Brambilla DJ; Strouse JJ; Maier P; Dlugash R; Avadhani R; Vermillion K; Tonascia J; Voeks JH; Hanley DF; Thompson RE; Lehmann HP
Clin Trials; 2019 Feb; 16(1):20-31. PubMed ID: 30426764
[TBL] [Abstract][Full Text] [Related]
22. Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial.
Debaun MR; Field JJ
Hematology Am Soc Hematol Educ Program; 2007; ():482-8. PubMed ID: 18024668
[TBL] [Abstract][Full Text] [Related]
23. The excess burden of stroke in hospitalized adults with sickle cell disease.
Strouse JJ; Jordan LC; Lanzkron S; Casella JF
Am J Hematol; 2009 Sep; 84(9):548-52. PubMed ID: 19623672
[TBL] [Abstract][Full Text] [Related]
24. First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?
Calvet D; Bernaudin F; Gueguen A; Hosseini H; Habibi A; Galactéros F; Bartolucci P
Stroke; 2015 Aug; 46(8):2315-7. PubMed ID: 26173728
[TBL] [Abstract][Full Text] [Related]
25. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
Galadanci NA; Umar Abdullahi S; Vance LD; Musa Tabari A; Ali S; Belonwu R; Salihu A; Amal Galadanci A; Wudil Jibir B; Bello-Manga H; Neville K; Kirkham FJ; Shyr Y; Phillips S; Covert BV; Kassim AA; Jordan LC; Aliyu MH; DeBaun MR
Am J Hematol; 2017 Aug; 92(8):780-788. PubMed ID: 28439953
[TBL] [Abstract][Full Text] [Related]
26. Trials in sickle cell disease.
Kirkham FJ; Lerner NB; Noetzel M; DeBaun MR; Datta AK; Rees DC; Adams RJ
Pediatr Neurol; 2006 Jun; 34(6):450-8. PubMed ID: 16765823
[TBL] [Abstract][Full Text] [Related]
27. [Sickle cell disease in Africa: current situation and strategies for improving the quality and duration of survival].
Diallo DA
Bull Acad Natl Med; 2008 Oct; 192(7):1361-72; discussion 1372-3. PubMed ID: 19445362
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
Bello-Manga H; DeBaun MR; Kassim AA
Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
[TBL] [Abstract][Full Text] [Related]
29. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
Mack AK; Thompson AA
J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
[TBL] [Abstract][Full Text] [Related]
30. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
Chaturvedi S; DeBaun MR
Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
[TBL] [Abstract][Full Text] [Related]
31. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal.
Lagunju IA; Brown BJ; Sodeinde OO
Pediatr Blood Cancer; 2013 Dec; 60(12):1940-5. PubMed ID: 23956197
[TBL] [Abstract][Full Text] [Related]
32. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
[TBL] [Abstract][Full Text] [Related]
33. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging.
Gold JI; Johnson CB; Treadwell MJ; Hans N; Vichinsky E
Pediatr Hematol Oncol; 2008 Jun; 25(5):409-21. PubMed ID: 18569843
[TBL] [Abstract][Full Text] [Related]
34. The cost of health care for children and adults with sickle cell disease.
Kauf TL; Coates TD; Huazhi L; Mody-Patel N; Hartzema AG
Am J Hematol; 2009 Jun; 84(6):323-7. PubMed ID: 19358302
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
[TBL] [Abstract][Full Text] [Related]
36. Cerebrovascular disease in sickle cell disease.
Alakbarzade V; Maduakor C; Khan U; Khandanpour N; Rhodes E; Pereira AC
Pract Neurol; 2023 Apr; 23(2):131-138. PubMed ID: 36123118
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
38. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
[TBL] [Abstract][Full Text] [Related]
39. Prevention and management of strokes in patients with sickle cell disease.
Abboud MR; Atweh GF
Curr Hematol Rep; 2006 Mar; 5(1):15-22. PubMed ID: 16537042
[TBL] [Abstract][Full Text] [Related]
40. Neurologic complications of sickle cell disease.
Venkataraman A; Adams RJ
Handb Clin Neurol; 2014; 120():1015-25. PubMed ID: 24365368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
